Further research is warranted to explore the correlation between HBP and hepcidin, respectively, and with possibly better biomarkers for acute kidney injury such as cystatin C. Cystatin C is a biomarker known to have advantages over serum-creatinine [46,54]. The gene discussed is HAMP; the disease is acute kidney injury.